✦ LIBER ✦

Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials

✍ Scribed by Martina Lukasova; Julien Hanson; Sorin Tunaru; Stefan Offermanns

Book ID: 116919071
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 495 KB
Volume: 32
Category: Article
ISSN: 0165-6147
DOI: 10.1016/j.tips.2011.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid in cholestasis: Pot

Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications

✍ Ulrich Beuers; James L. Boyer; Gustav Paumgartner 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

The dihydroxy bile acid, ursodeoxycholic acid (UDCA), is increasingly used for the treatment of chronic cholestatic liver diseases. First reports of a beneficial effect on serum liver tests in cholestatic disorders were published in the 1980s in the Western literature, 1-3 but similar observations h

In vivo impact of prodrug isosorbide-5-n

In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: Is this a new immediate-release therapeutic option for niacin?

✍ Mark T. Ledwidge; Fiona Ryan; David M. Kerins; Damian O’Connell; Gene Cefali; Sh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 464 KB

Topical capsaicin for pain management: t

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

✍ Anand, P.; Bley, K. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 563 KB

The endocannabinoid system and rimonaban

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use

✍ S. Xie; M. A. Furjanic; J. J. Ferrara; N. R. McAndrew; E. L. Ardino; A. Ngondara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB